Abstract
Resazurin microtitre assay (RMA) has been successfully used to detect minimal inhibitory concentrations (MICs) of both first-line and several second-line drugs in drug susceptibility testing (DST) of Mycobacterium tuberculosis (MTB). In this study, we firstly compared prothionamide (PTH) susceptibility testing of Mycobacterium tuberculosis (MTB) using resazurin microtitre assay (RMA) and MGIT. Overall, the sensitivity and specificity of RMA for detecting PTH susceptibility was 96.5% [95% confidence interval (CI): 91.7–100.0] and 93.2% (95% CI: 89.6–96.8) respectively. In addition, the median time to positivity was significantly shorter for RMA than for the automated MGIT 960 (RMA, 8 days [range: 8–8 days] vs MGIT, 10.1 days, [range: 5.0–13.0]; P < 0.01). Concordance rate for MICs between RMA and MGIT for PTH-resistant group was 64.3% (95% CI: 46.5–82.0), which was significantly lower than that of PTH-susceptible group (85.9%, 95% CI: 78.8–93.0; P= 0.01). In conclusion, our data demonstrated that RMA can be used as an acceptable alternative for determination of PTH susceptibility with shorter turn-around time. When compared with MGIT 960, RMA method was prone to produce higher MICs for PTH-resistant MTB strains.
Similar content being viewed by others
References
Wang F, Langley R, Gulten G et al (2007) Mechanism of thioamide drug action against tuberculosis and leprosy. J Exp Med 204(1):73–78
Falzon D, Jaramillo E, Schunemann HJ et al (2011) WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 38(3):516–528
World Health Organization (2008) Policy guidance on drug-susceptibility testing (DST) of second-line antituberculosis drugs. WHO/HTM/TB/2008.392
Wells WA, Boehme CC, Cobelens FG et al (2013) Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action. Lancet Infect Dis 13(5):449–458
Sethi S, Mandal J, Kumar P et al (2007) Susceptibility testing of Mycobacterium tuberculosis by broth microdilution method: a rapid alternative method. Diagn Microbiol Infect Dis 57(4):447–449
Martin A, Camacho M, Portaels F, Palomino JC (2003) Resazurin microtiter assay plate testing of Mycobacterium tuberculosis susceptibilities to second-line drugs: rapid, simple, and inexpensive method. Antimicrob Agents Chemother 47(11):3616–3619
Zhang Z, Wang Y, Pang Y, Liu C (2014) Comparison of different drug susceptibility test methods to detect rifampin heteroresistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 58(9):5632–5635
Zhang Z, Wang Y, Pang Y, Kam KM (2014) Ethambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates. J Clin Microbiol 52(2):638–641
van Ingen J, Simons S, de Zwaan R et al (2010) Comparative study on genotypic and phenotypic second-line drug resistance testing of Mycobacterium tuberculosis complex isolates. J Clin Microbiol 48(8):2749–2753
Kruuner A, Yates MD, Drobniewski FA (2006) Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis. J Clin Microbiol 44(3):811–818
Rusch-Gerdes S, Pfyffer GE, Casal M, Chadwick M, Siddiqi S (2006) Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials. J Clin Microbiol 44(3):688–692
Lefford MJ, Mitchison DA (1966) Comparison of methods for testing the sensitivity of Mycobacterium tuberculosis to ethionamide. Tubercle 47(3):250–261
Gazi MA, Islam MR, Kibria MG, Mahmud Z (2015) General and advanced diagnostic tools to detect Mycobacterium tuberculosis and their drug susceptibility: a review. Eur J Clin Microbiol Infect Dis 34(5):851–861
Heysell SK, Pholwat S, Mpagama SG et al (2015) Sensititre MycoTB plate compared to Bactec MGIT 960 for first- and second-line antituberculosis drug susceptibility testing in Tanzania: a call to operationalize MICs. Antimicrob Agents Chemother 59(11):7104–7108
Acknowledgements
We would like to thank members of the National Tuberculosis Reference Laboratory at the Chinese Center for Disease Control and Prevention for their technical assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This work was supported by the National Key Research Program of China (2014ZX10003002).
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
This study was approved by the Ethics Committee of Beijing Chest Hospital affiliated to Capital Medical University.
Rights and permissions
About this article
Cite this article
Tan, Y., Su, B., Zheng, H. et al. Prothionamide susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTECMGIT 960 system. Eur J Clin Microbiol Infect Dis 36, 779–782 (2017). https://doi.org/10.1007/s10096-016-2859-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-016-2859-6